Search - tctmd.com

Displaying 1 - 7 of 7

Sort: Relevancy | Date

Presentation ESC 2024

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

Presenter: David Erlinge

September 02, 2024

Presentation ESC 2023

OCT versus Angiography Guided PCI ILUMIEN IV: OPTIMAL PCI

Presenter: Ziad A Ali

August 28, 2023

Presentation ESC 2022

Impact on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: a meta-analysis of individual patient data from seven multicenter randomized clinical trials

Presenter: Giuseppe Gargiulo

August 29, 2022

Presentation ESC 2022

FFR vs. Angiography-guided PCI in AMI with multivessel disease

Presenter: Joo-Yong Hahn

August 29, 2022

Presentation ESC 2016

CE-MARC 2 Trial: A Prospective, Multi-Centre, Randomized Trial Of 3 Diagnostic Strategies In Suspected Coronary Heart Disease (CMR vs UK NICE Guidelines vs MPS-SPECT)

Presenter: John P. Greenwood

August 29, 2016

Presentation ESC 2015

12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs_ metallic DES in de novo native coronary artery lesions

Presenter: Takeshi Kimura

September 01, 2015

Presentation ESC 2012

Diagnostic Accuracy of Fractional Flow Reserve from Anatomic Computed Tomographic Angiography: The DeFACTO Study

Presenter: James K. Min

August 28, 2012

Advertisement

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

OCT versus Angiography Guided PCI ILUMIEN IV: OPTIMAL PCI

Impact on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: a meta-analysis of individual patient data from seven multicenter randomized clinical trials

FFR vs. Angiography-guided PCI in AMI with multivessel disease

CE-MARC 2 Trial: A Prospective, Multi-Centre, Randomized Trial Of 3 Diagnostic Strategies In Suspected Coronary Heart Disease (CMR vs UK NICE Guidelines vs MPS-SPECT)

12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs_ metallic DES in de novo native coronary artery lesions

Diagnostic Accuracy of Fractional Flow Reserve from Anatomic Computed Tomographic Angiography: The DeFACTO Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content